Stock price performance of Chemours Company (The) is analyzed for various periods using several stock trading signals. In this case, The stock price has rallied 33.37% in the past 12 Weeks , but analyzing the 6 month charts for the stock , the price continues to stay positive and keep the rally at 123.1% . Looking at the past 52 week period, the stock price is up at 562.35% . Relative price strength is a important factor used by wealth management firms while investing in stocks because the indicator compares the stock performance with the overall market. The relative price strength of Chemours Company (The) has a positive value of 215.57 compared to overall market. Company shares have received an average consensus rating of Hold for the current week The stock has recorded a 20-day Moving Average of 7.32% and the 50-Day Moving Average is 6.3%.The 200 Day SMA reached 72.86%
The Chemours Company is having a Relative Strength Index of 67.12 which indicates the stock is not yet over sold or over bought based on the technical indicators. Chemours Company (The) (NYSE:CC) has climbed 8.78% in the past week and advanced 28.23% in the last 4 weeks. In the past week, the company has outperformed the S&P 500 by 8.65% and the outperformance has advanced to 27.09% for the last 4 weeks period.
Company has reported several Insider transactions to the SEC, on May 18, 2016, Mark Newman (CFO) purchased 2,800 shares at 9.70 per share price.On May 6, 2016, Bradley J Bell (director) purchased 10,000 shares at 9.65 per share price.On Feb 29, 2016, Stephen D Newlin (director) purchased 10,000 shares at 4.95 per share price.
Chemours Co Last issued its quarterly earnings results on Nov 7, 2016. The company reported $0.61 EPS for the quarter, beating the analyst consensus estimate by $ 0.27. Analyst had a consensus of $0.34. The company had revenue of $1398.00 million for the quarter, compared to analysts expectations of $1397.42 million. The companys revenue was down -5.9 % compared to the same quarter last year.During the same quarter in the previous year, the company posted $0.40 EPS.
Several Stock Research Financial Advisors from Investment Banking firms have advised their client and investors on the stock.Chemours Co was Downgraded by Goldman to Neutral on Dec 12, 2016.
Chemours Company (The) (NYSE:CC) : On Friday heightened volatility was witnessed in Chemours Company (The) (NYSE:CC) which led to swings in the share price. The stock opened for trading at $26.97 and hit $27.69 on the upside , eventually ending the session at $27.62, with a gain of 2.79% or 0.75 points. The heightened volatility saw the trading volume jump to 2,336,733 shares. The 52-week high of the share price is $27.69 and the company has a market cap of $5,022 million. The 52-week low of the share price is at $3.5 .
Chemours Company is involved in chemical business. It operating segment consists of Titanium Technologies, Fluoroproducts and Chemical Solutions. Titanium Technologies segment produces titanium dioxide and premium white pigment. Fluoroproducts segment provides fluoroproducts, refrigerants and industrial fluoropolymer resins. Chemical Solutions segment provides industrial and specialty chemicals. The companys brand consists of Teflon(R), Ti-Pure(R), Krytox(R) Viton(R), Opteon(R) and Nafion(R). Chemours Company is headquartered in Wilmington.